Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2000
10/05/2000WO2000027880A3 Rantes-derived peptides with anti-hiv activity
10/05/2000WO2000027421A3 LOCAL USE OF SOLUBLE TUMOR NECROSIS RECEPTOR I (sTNFRI) FOR PROPHYLAXIS AND TREATMENT OF CORNEAL TRANSPLANT REJECTION AND OTHER DISORDERS OF THE EYE
10/05/2000WO2000026246A3 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000023088A3 Methods of administering adenoviral vectors
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO2000001716A3 Vasculoprotector
10/05/2000WO1998041232A3 Compositions for modulating responsiveness to corticosteroids
10/05/2000DE19914621A1 Stable aqueous solution of the thalidomide derivative EM 12 for parenteral administration in isotonic glucose solution has a specified pH, useful for treating immunological, hematologic and oncologic diseases
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368744A1 Value-added traits in grain and seed transformed with thioredoxin
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368463A1 Phosphate containing macrocyclic immunomodulators
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368376A1 50 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2367424A1 Hookworm platelet inhibitor
10/05/2000CA2366604A1 Modulators of polysaccharides and uses thereof
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000CA2362409A1 Sulfamate containing macrocyclic immunomodulators
10/05/2000CA2361366A1 Novel compounds
10/05/2000CA2329152A1 Peptide vaccine for canine allergy
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040191A2 Rantes mutants and therapeutic applications thereof
10/04/2000EP1040187A2 Human protein kinase and kinase inhibitors
10/04/2000EP1040123A2 Human papillomavirus vaccine
10/04/2000EP1040118A1 Secreted proteins and polynucleotides encoding them
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1039933A2 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
10/04/2000EP1039930A2 Adjuvanted vaccine formulation
10/04/2000EP1039906A1 Novel metal complexes
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000CN1268953A Ligand for herps simplex virus entry mediator and method of use
10/04/2000CN1268886A Treatment of cell-mediated immune diseases
10/04/2000CN1268563A Gene engineering preparation method of Chinese human being costimulation signal inhibition factor
10/04/2000CN1268378A Injection capable of raising immunity of fowl and livestock and makig their meat, egg and milk into health-care products
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/04/2000CN1057012C Method for prod. of BCRF1 proteins as inhibitors of interferon-gamma
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
10/03/2000US6127426 Antiallergic and -inflammatory agents e.g., treating psoriasis, blocked on the c-10 by a nonphenolic arylacyl or a phenylalkylidene group; lipoxygenase inhibitors; antiproliferative agents; low dosage; side effect reduction
10/03/2000US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments
10/03/2000US6127408 Thioether furan nitrone compounds; nervous system degenerative disorders, e.g. alzheimer's disease; analysis of free radicals by forming adducts; inhibit the forming of a beta(1-42) beta-pleated sheets and/or suppressing cytokines
10/03/2000US6127402 5-aroylpyrrol-2-ylmethylarene derivatives
10/03/2000US6127398 An enzyme inhibitor for the inhibition of phosphodiesterase typeiv or the production of tumor necrosis factor in a mammal; treating asthma, arthritis, bronchitis, chronic obstructive airway disease, psoriasis, allergic rhinitis
10/03/2000US6127387 Use of CD4-binding small molecules to inhibit immune responses
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127345 Utilizing glucose 6-phosphate dehydrogenase gene polypeptide for the protection against infection, particularly bacterial infections
10/03/2000US6127332 Muteins of IFN-β
10/03/2000US6127169 Non-agglutinating β-galactoside binding protein and its encoding nucleic acid
10/03/2000US6127163 Viral vector which codes exogenous proteins; for use as therapeutic tools in drug delivery
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000CA2000342C Novel peptidase inhibitors
09/2000
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056720A1 Quinazolines and therapeutic use thereof
09/28/2000WO2000056709A1 Indolinone compounds as kinase inhibitors
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1172